| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fabricio A Pamplona, Lorenzo Rolim da Silva, Ana Carolina Coa. Potential Clinical Benefits of CBD-Rich Frontiers in neurology. vol 9. 2020-10-01. PMID:30258398. |
the systematic search took place in february/2017 and updated in december/2017 using the keywords "epilepsy" or "dravet" or "lennox-gastaut" or "cdkl5" combined with "cannabis," "cannabinoid," "cannabidiol," or "cbd" resulting in 199 papers. |
2020-10-01 |
2023-08-13 |
Not clear |
| Maria Scherma, Paolo Masia, Matteo Deidda, Walter Fratta, Gianluigi Tanda, Paola Fadd. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. Medicines (Basel, Switzerland). vol 5. issue 4. 2020-10-01. PMID:30279403. |
following the discovery of the endocannabinoid system and its potential as a therapeutic target for various pathological conditions, growing interest led researchers to investigate the role of cannabis and its derivatives for medical purposes. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jamie Corroon, Rod Kigh. Regulatory Status of Cannabidiol in the United States: A Perspective. Cannabis and cannabinoid research. vol 3. issue 1. 2020-10-01. PMID:30283822. |
cannabidiol (cbd) is 1 of > 100 cannabinoids found in |
2020-10-01 |
2023-08-13 |
Not clear |
| Pramod Theetha Kariyanna, Apoorva Jayarangaiah, Sudhanva Hegde, Jonathan D Marmur, Perry Wengrofsky, Mena Yacoub, Michael Post, Samy I McFarlan. Marijuana Induced Type I Brugada Pattern: A Case Report. American journal of medical case reports. vol 6. issue 7. 2020-10-01. PMID:30294671. |
marijuana acts on cannabinoid receptors cb1, cb2 and another distinct endothelial receptor. |
2020-10-01 |
2023-08-13 |
Not clear |
| Perry Wengrofsky, Ghassan Mubarak, Ahmed Shim, Pramod Theetha Kariyanna, Adam Buzidkowski, Jacob Schwartz, Samy I McFarlan. Recurrent STEMI Precipitated by Marijuana Use: Case Report and Literature Review. American journal of medical case reports. vol 6. issue 8. 2020-10-01. PMID:30294673. |
delta 9-tetrahydrocannibol, the main psychoactive compound in marijuana, acts via the endocannabinoid system to elicit various cardiovascular physiological effects, and has been associated with many adverse cardiovascular effects such as acute coronary syndrome, arrhythmias, and sudden cardiac death that have previously been reported by our group and others. |
2020-10-01 |
2023-08-13 |
Not clear |
| Hyunyoung G Kim, Jeremiah Moon, Heather Dixon, Paul Tulla. Recurrent Nausea and Vomiting in a Pregnant Woman with Chronic Marijuana Use. Case reports in obstetrics and gynecology. vol 2018. 2020-10-01. PMID:30305971. |
cannabinoid hyperemesis syndrome is a condition characterized by chronic cannabis use and cyclic episodes of nausea, vomiting, and abdominal pain, relieved by compulsive bathing. |
2020-10-01 |
2023-08-13 |
Not clear |
| Verena Angerer, Florian Franz, Bjoern Moosmann, Philippe Bisel, Volker Auwärte. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA. Forensic toxicology. vol 37. issue 1. 2020-10-01. PMID:30636986. |
a new trend is the use of e-liquids containing synthetic cannabinoids (scs) instead of smoking cannabis or herbal mixtures laced with scs. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jing Wang, Yanling Wang, Mengting Tong, Hongming Pan, Da L. New Prospect for Cancer Cachexia: Medical Cannabinoid. Journal of Cancer. vol 10. issue 3. 2020-10-01. PMID:30719170. |
cannabinoid, such as Δ-9-tetrahydrocannabinol (thc) and cannabidiol, is one of a class of diverse chemical compounds. |
2020-10-01 |
2023-08-13 |
Not clear |
| Cinzia Citti, Pasquale Linciano, Sara Panseri, Francesca Vezzalini, Flavio Forni, Maria Angela Vandelli, Giuseppe Cannazz. Cannabinoid Profiling of Hemp Seed Oil by Liquid Chromatography Coupled to High-Resolution Mass Spectrometry. Frontiers in plant science. vol 10. 2020-10-01. PMID:30815007. |
besides tetrahydrocannabinol and cannabidiol, other 30 cannabinoids were identified for the first time in hemp seed oil. |
2020-10-01 |
2023-08-13 |
human |
| Yann Chye, Erynn Christensen, Nadia Solowij, Murat Yüce. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder. Frontiers in psychiatry. vol 10. 2020-10-01. PMID:30837904. |
the endocannabinoid system and cannabidiol's promise for the treatment of substance use disorder. |
2020-10-01 |
2023-08-13 |
human |
| Chelsea R Kasten, Yanping Zhang, Stephen L Boeh. Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent. Frontiers in behavioral neuroscience. vol 13. 2020-10-01. PMID:30842732. |
the rise in cannabinoid legalization and decriminalization in the us has been paired with an increase in adolescents that perceive marijuana as a "no risk" drug. |
2020-10-01 |
2023-08-13 |
mouse |
| Chelsea R Kasten, Yanping Zhang, Stephen L Boeh. Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent. Frontiers in behavioral neuroscience. vol 13. 2020-10-01. PMID:30842732. |
although the cannabinoids Δ9-tetrahydrocannabinol (thc) and cannabidiol (cbd) are often used together for recreational and medical purposes, no study has previously observed the acute and long-lasting effects of thc+cbd in a battery of behavioral assays analogous to subjective human reports. |
2020-10-01 |
2023-08-13 |
mouse |
| Nicole Tartaglia, Marcel Bonn-Miller, Randi Hagerma. Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature. Cannabis and cannabinoid research. vol 4. issue 1. 2020-10-01. PMID:30944868. |
cannabidiol (cbd) is an exogenous phytocannabinoid with therapeutic potential for individuals with anxiety, poor sleep, and cognitive deficits, as well as populations with endocannabinoid deficiencies, such as those who suffer from fxs. |
2020-10-01 |
2023-08-13 |
human |
| Éric Samarut, Jessica Nixon, Uday P Kundap, Pierre Drapeau, Lee D Elli. Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:30949046. |
in this study, we aimed to investigate the effect of the two main active cannabinoids extracted from cannabis: Δ-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) on two distinct behavioral models of induced neuro-hyperactivity. |
2020-10-01 |
2023-08-13 |
zebrafish |
| Pratima Dibba, Andrew A Li, George Cholankeril, Muhammad Ali Khan, Donghee Kim, Aijaz Ahme. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutrition and metabolic insights. vol 12. 2020-10-01. PMID:31308686. |
this commentary combines knowledge on the role of the endocannabinoid system in the setting of nafld with the findings in our article to hypothesize different potential mechanisms that may influence the inverse relationship between cannabis and nafld. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ivan Herreros, Laia Miquel, Chrysanthi Blithikioti, Laura Nuño, Belen Rubio Ballester, Klaudia Grechuta, Antoni Gual, Mercè Balcells-Oliveró, Paul Verschur. Motor Adaptation Impairment in Chronic Cannabis Users Assessed by a Visuomotor Rotation Task. Journal of clinical medicine. vol 8. issue 7. 2020-10-01. PMID:31323815. |
the cerebellum is expected to be one of the brain structures that are highly affected by prolonged exposure to cannabis, due to its high density in endocannabinoid receptors. |
2020-10-01 |
2023-08-13 |
Not clear |
| Albert Batalla, Hella Janssen, Shiral S Gangadin, Matthijs G Bosson. The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review. Journal of clinical medicine. vol 8. issue 7. 2020-10-01. PMID:31330972. |
the non-psychoactive cannabinoid compound, cannabidiol (cbd) is a highly promising tool in the treatment of both disorders. |
2020-10-01 |
2023-08-13 |
human |
| Ali Alqahtani, Zaid Ammari, Ahmad Ramahi, Tamer S Said Ahmed, Emile Klad. Cannabis Smoking-induced Diffuse Alveolar Hemorrhage. Cureus. vol 11. issue 7. 2020-10-01. PMID:31511809. |
moreover, in vitro coagulation studies on rats showed that two major cannabinoids, cannabinol and thc, have antithrombotic activity. we present two cases of cannabis use resulting in acute lung injury and diffuse alveolar hemorrhage. |
2020-10-01 |
2023-08-13 |
rat |
| Pramod Theetha Kariyanna, Perry Wengrofsky, Apoorva Jayarangaiah, Syed Haseeb, Louis Salciccioli, Sudhanva Hegde, Jonathan D Marmur, Yasmin Soliman, Sama Al-Bayati, Samy I McFarlan. Marijuana and Cardiac Arrhythmias: A Scoping Study. International journal of clinical research & trials. vol 4. issue 1. 2020-10-01. PMID:31579321. |
delta-9-tetrahydrocannabinol (thc) is the active psychotropic component of marijuana, which acts mainly on g-protein cannabinoid receptors cb1 and cb2. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kent E Hutchison, Sarah L Hagerty, Jeffrey Galinkin, Angela D Bryan, L Cinnamon Bidwel. Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data. Cannabis and cannabinoid research. vol 4. issue 3. 2020-10-01. PMID:31579833. |
given the number of people in the united states who are already using cannabis to manage pain and opioid use in state-regulated markets, it is imperative to conduct additional research in these areas, and to disseminate information on how to minimize harm and maximize any benefits of using cannabinoids to mitigate pain and reduce opioid use. |
2020-10-01 |
2023-08-13 |
Not clear |